Equities

Cytori Cell Research Institute Inc

3750:TYO

Cytori Cell Research Institute Inc

Actions
Real EstateReal Estate Investment and Services
  • Price (JPY)950.00
  • Today's Change4.00 / 0.42%
  • Shares traded4.30k
  • 1 Year change-15.10%
  • Beta0.7067
Data delayed at least 20 minutes, as of Apr 26 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Cytori Cell Research Institute Inc is a Japan-based company mainly engaged in the real asset business. The Company operates through two segments. The Real Asset segment is engaged in the purchase and sales of real estate and investment of real estate business related projects, as well as development, renovation and opening of hotels, and operation of hotels. The Medical segment is engaged in the investment of regenerative medicine business centered on cell therapy services, as well as sales of medical equipment and consumables. The main products include Celusion centrifuge and the Celusion cell therapy kit.

  • Revenue in JPY (TTM)1.90bn
  • Net income in JPY-889.78m
  • Incorporated2004
  • Employees64.00
  • Location
    Cytori Cell Research Institute Inc7FOtemachi Park Bldg., 1-1-1, Ote-machiCHIYODA-KU 100-0004JapanJPN
  • Phone+81 368605701
  • Fax+81 368605702
  • Websitehttps://cytori.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ambition DX Holdings Co Ltd38.18bn1.07bn6.53bn340.006.461.314.590.171146.96146.965,404.95726.351.873.58118.67112,283,900.005.274.259.006.5318.9319.122.822.220.745613.970.730217.2514.659.2616.369.4624.065.92
Escrow Agent Japan Inc4.14bn299.84m6.57bn220.0020.811.8013.721.596.876.8794.8479.440.9532--8.57--6.917.488.628.9046.3846.487.258.20--1,143.09--64.0411.535.90226.070.5722-1.5311.38
Landix Inc15.72bn613.58m6.65bn89.0010.920.983810.090.423214.93214.935,521.732,386.631.041.85--176,673,800.004.077.846.9312.2617.9724.133.907.500.78311.090.557316.3634.9321.8912.0619.1753.28--
Landnet Inc69.23bn999.37m6.82bn581.006.870.89775.360.0986166.72166.7211,541.981,276.573.515.601,764.15119,162,100.005.07--9.40--14.00--1.44--0.432811.060.6072--22.70--3.39------
PROPERST Co., Ltd.23.58bn1.85bn6.89bn44.003.670.63264.150.292153.4453.44684.29309.810.81590.898747,166.00535,977,300.006.404.2910.998.8920.6318.047.855.330.61188.460.6156.0713.153.4437.6216.690.000.00
LAND BUSINESS CO., LTD.4.56bn1.07bn7.07bn205.004.920.27763.651.5553.6953.69229.79950.890.0860.748448.4722,246,320.002.010.6452.230.686935.4738.5523.377.661.32-0.6890.594635.44-3.34-0.122430.95-5.13-1.270.00
Space Shower Skiyaki Holdings Inc16.63bn490.54m7.20bn241.007.220.88249.330.433258.5558.551,984.82479.392.2853.269.3369,001,340.006.752.3710.493.7117.7919.852.961.261.83--0.000554.1210.940.3882-39.290.89867.010.00
Housecom Corp13.44bn207.82m7.27bn1.09k38.131.1112.310.540724.4724.471,728.18844.111.36119.4840.6212,298,240.002.115.212.837.212.4392.021.553.952.25--0.0035.94-0.19335.55-12.23-17.4913.78-13.74
W TOKYO Inc3.69bn394.52m7.63bn44.0019.474.9913.162.07145.17145.171,363.72566.901.28--14.5483,824,660.0013.67--18.85--42.66--10.70----72.750.3902--75.08--215.12------
Ichigo Green Infrastructure Investm Corp1.04bn189.52m7.77bn--41.022.209.387.441,840.641,840.6410,144.2934,376.550.1208--7.02--2.191.742.321.8228.8729.2218.1417.01--4.270.5721100.00-3.20-1.88-8.68-1.74-61.07-1.74
Livero Inc2.90bn103.94m8.33bn141.0088.654.3258.522.8717.6717.67534.14362.880.7385--7.5220,573,660.002.65--3.94--84.82--3.58------0.00--13.54--104.69------
Cytori Cell Research Institute Inc1.90bn-889.78m8.45bn64.00--4.02--4.44-99.66-99.66213.30235.210.13692.67--29,757,270.00-6.39-1.57-7.13-1.7179.3451.84-46.69-12.570.4786-5.700.7867--60.5832.65-1,265.32------
Apaman Co Ltd45.50bn415.00m8.83bn1.07k20.632.293.960.194223.1223.122,534.83208.461.3419.6733.1442,720,190.001.281.132.051.6624.0123.800.95610.8661.056.670.809998.911.911.90118.70---16.437.39
Sansei Landic Co Ltd23.27bn1.18bn8.90bn187.007.210.70767.050.3826143.91143.912,826.971,465.490.77620.69051,451.09124,433,200.003.953.897.496.7027.2627.195.084.780.26387.930.582925.6449.806.6911.603.2835.647.39
Tokyo Theatres Co Inc17.30bn-51.46m9.04bn435.00--0.652533.040.5225-6.78-6.782,398.691,728.810.71053.9927.4139,770,000.00-0.207-0.8725-0.2577-1.0625.6424.95-0.2914-1.380.9453--0.3363--24.98-2.20-77.2331.83-22.110.00
Choei Inc9.20bn1.49bn9.81bn242.006.530.94173.411.07336.14336.142,072.012,329.800.1597110.8637.1038,022,450.002.59--2.76--38.09--16.22--2.624.260.813--8.10---12.34------
Data as of Apr 26 2024. Currency figures normalised to Cytori Cell Research Institute Inc's reporting currency: Japanese Yen JPY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.